BWX Technologies, Inc.: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 6, 2018 and accepted by EDGAR at Aug 6, 2018, 16:48 ET.
Management's discussion and analysis
As filed, 44,157 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included under Item 1 of this quarterly report on Form 10-Q ("Report") and the audited consolidated financial statements and the related notes and Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our annual report on Form 10-K for the year ended December 31, 2017 (our "2017 10-K").
In this Report, unless the context otherwise indicates, "we," "us" and "our" mean BWX Technologies, Inc. ("BWXT") and its consolidated subsidiaries.
From time to time, our management or persons acting on our behalf make forward-looking statements to inform existing and potential security holders about our company. In addition, various statements in this Report, including those that express a belief, expectation or intention, as well as those that are not statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934. Statements and assumptions regarding expectations and projections of specific projects, our future backlog, revenues, income, capital spending, strategic investments, acquisitions or divestitures, research and development initiatives, return on capital activities or margin improvement initiatives are examples of forward-looking statements. Forward-looking statements are generally accompanied by words such as "estimate," "project," "predict," "believe," "expect," "anticipate," "plan," "seek," "goal," "could," "intend," "may," "should" or other words that convey the uncertainty of future events or outcomes. In addition, sometimes we will specifically describe a statement as being a forward-looking statement and refer to this cautionary statement.
We have based our forward-looking statements on our current expectations, estimates and projections about our industries and our company. We caution that these statements are not guarantees of future performance and you should not rely unduly on them, as they involve risks, uncertainties and assumptions that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. While our management considers these assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements.
We believe the items we have outlined above are important factors that could cause estimates in our financial statements to differ materially from actual results and those expressed in a forward-looking statement made in this Report or elsewhere by us or on our behalf. Differences between actual results and any future performance suggested in our forward-looking statements could result from a variety of factors. We have discussed many of these factors in more detail elsewhere in this Report and in Item 1A "Risk Factors" in our 2017 10-K. These factors are not necessarily all the factors that could affect us. Unpredictable or unanticipated factors we have not discussed in this Report or in our 2017 10-K could also have material adverse effects on actual results of matters that are the subject of our forward-looking statements. We do not intend to update our description of important factors each time a potential important factor arises, except as required by applicable securities laws and regulations. We advise our security holders that they should (1) be aware that factors not referred to above could affect the accuracy of our forward-looking statements and (2) use caution and common sense when considering our forward-looking statements.
GENERAL
We operate in three reportable segments: Nuclear Operations Group, Nuclear Services Group and Nuclear Power Group. In general, we operate in capital-intensive industries and rely on large contracts for a substantial amount of our revenues. We are currently exploring growth strategies across our segments to expand and complement our existing businesses. We would expect to fund these opportunities with cash on hand or by raising additional capital through debt, equity or some combination thereof.
Nuclear Operations Group
The revenues of our Nuclear Operations Group segment are largely a function of defense spending by the U.S. Government. Through this segment, we engineer, design and manufacture precision naval nuclear components, reactors and nuclear fuel for the DOE/NNSA's Naval Nuclear Propulsion Program. In addition, we perform missile launch tube development and fabrication activities for use on submarines. As a supplier of major nuclear components for certain U.S. Government programs, this segment is a significant participant in the defense industry.
Nuclear Services Group
Our Nuclear Services Group segment provides various services to the U.S. Government and the commercial nuclear industry primarily in the U.S. The revenues and equity in income of investees under our U.S. Government contracts are largely a function of spending of the U.S. Government and the performance scores we and our consortium partners earn in managing and operating high-consequence operations at U.S. nuclear weapons sites, national laboratories and manufacturing complexes. With its specialized capabilities of full life-cycle management of special materials, facilities and technologies, we believe our Nuclear Services Group segment is well-positioned to continue to participate in the continuing cleanup, operation and management of critical government-owned nuclear sites, laboratories and manufacturing complexes maintained by the DOE, NASA and other federal agencies.
This segment is also engaged in inspection and maintenance services for the commercial nuclear industry primarily in the U.S. These services include the inspection of steam generators and heat exchangers, high pressure water lancing, non-destructive examination and the development of customized tooling solutions. This segment also develops technology for a variety of applications, including advanced nuclear power sources, and offers complete advanced fuel and reactor engineering, licensing and manufacturing services for new advanced nuclear reactors.
Nuclear Power Group
Through this segment, we design and manufacture commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. This segment is a leading supplier of nuclear fuel, fuel handling systems, tooling delivery systems and related services for CANDU nuclear power plants. This segment also provides a variety of engineering and in-plant services and is a significant supplier to nuclear power utilities undergoing major refurbishment and plant life extension projects.
Our Nuclear Power Group segment's overall activity primarily depends on the demand and competitiveness of nuclear energy. A significant portion of our Nuclear Power Group segment's operations depend on the timing of maintenance outages, principally in the Canadian market, and the cyclical nature of capital expenditures and major refurbishments for nuclear utility customers, which could cause variability in our financial results.
Acquisition of Sotera Health LLC's Nordion Medical Isotope Business
On April 17, 2018, we signed a definitive agreement to acquire Sotera Health LLC's Nordion medical isotope business. Nordion's medical radioisotopes business is a leading global manufacturer and supplier of critical medical isotopes and radiopharmaceuticals for research, diagnostic and therapeutic uses. Its customers include radiopharmaceutical companies, hospitals and radiopharmacies. Its primary operations are located in Kanata, Ontario and Vancouver, British Columbia. This acquisition was completed on July 30, 2018 and will allow us to accelerate our entry into the medical radioisotope market by adding licensed infrastructure, approximately 150 highly trained and experienced personnel and two production centers. Beginning in the third quarter of 2018, this business will be reported as part of our Nuclear Power Group segment.
Critical Accounting Policies and Estimates
For a summary of the critical accounting policies and estimates that we use in the preparation of our unaudited condensed consolidated financial statements, see Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2017 10-K. There have been no material changes to our policies during the six months ended June 30, 2018 with the exception of changes to FASB Topics Revenue from Contracts with Customers and Compensation – Retirement Benefits as described in the notes to our condensed consolidated financial statements in Item 1 of our Form 10-Q for the quarter ended March 31, 2018.
Accounting for Contracts
On certain of our performance obligations, we recognize revenue over time. In accordance with FASB Topic Revenue from Contracts with Customers, we are required to estimate the total amount of costs on these performance obligations. As of June 30, 2018, we have provided for the estimated costs to complete all of our ongoing contracts. However, it is possible that current estimates could change due to unforeseen events, which could result in adjustments to overall contract costs. A principal risk on fixed-priced contracts is that revenue from the customer is insufficient to cover increases in our costs. It is possible that current estimates could materially change for various reasons, including, but not limited to, fluctuations in forecasted labor productivity or steel and other raw material prices. In some instances, we guarantee completion dates related to our projects or provide performance guarantees. Increases in costs on our fixed-price contracts could have a material adverse impact on our consolidated results of operations, financial condition and cash flows. Alternatively, reductions in overall contract costs at completion could materially improve our consolidated results of operations, financial condition and cash flows. In the six months ended June 30, 2018 and 2017, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased operating income by approximately $14.5 million and $11.2 million, respectively.
RESULTS OF OPERATIONS – THREE AND SIX MONTHS ENDED JUNE 30, 2018 VS. THREE AND SIX MONTHS ENDED JUNE 30, 2017
Selected financial highlights are presented in the table below:
(In thousands)
| REVENUES: | Three Months Ended June 30, 2018 | 2017 | $ Change | Six Months Ended June 30, 2018 | 2017 | $ Change |
|---|---|---|---|---|---|---|
| Nuclear Operations Group | $332,140 | $312,866 | $19,274 | $648,771 | $637,947 | $10,824 |
| Nuclear Services Group | 32,596 | 44,785 | (12,189) | 62,629 | 72,639 | (10,010) |
| Nuclear Power Group | 75,697 | 54,569 | 21,128 | 188,513 | 132,243 | 56,270 |
| Adjustments and Eliminations | (1,512) | (2,209) | 697 | (3,529) | (4,589) | 1,060 |
| $438,921 | $410,011 | $28,910 | $896,384 | $838,240 | $58,144 | |
| OPERATING INCOME: | ||||||
| Nuclear Operations Group | $67,046 | $69,295 | $(2,249) | $134,703 | $137,044 | $(2,341) |
| Nuclear Services Group | 3,511 | 15,399 | (11,888) | 4,688 | 15,801 | (11,113) |
| Nuclear Power Group | 7,810 | 5,712 | 2,098 | 29,574 | 18,668 | 10,906 |
| Other | (4,357) | (1,070) | (3,287) | (8,400) | (2,682) | (5,718) |
| $74,010 | $89,336 | $(15,326) | $160,565 | $168,831 | $(8,266) | |
| Unallocated Corporate | (2,461) | (3,908) | 1,447 | (9,128) | (7,131) | (1,997) |
| Total Operating Income | $71,549 | $85,428 | $(13,879) | $151,437 | $161,700 | $(10,263) |
Consolidated Results of Operations
Three months ended June 30, 2018 vs. 2017
Consolidated revenues increased 7.1%, or $28.9 million, to $438.9 million in the three months ended June 30, 2018 compared to $410.0 million for the corresponding period in 2017, due to increases in revenues from our Nuclear Operations Group and Nuclear Power Group segments totaling $19.3 million and $21.1 million, respectively. These increases were partially offset by a decrease in revenues in our Nuclear Services Group segment of $12.2 million, which was primarily related to $7.9 million of fee income associated with the settlement of a contract dispute that was recorded in 2017.
Consolidated operating income decreased $13.9 million to $71.5 million in the three months ended June 30, 2018 compared to $85.4 million for the corresponding period of 2017. Operating income in our Nuclear Operations Group, Nuclear Services Group and Other segments decreased $2.2 million, $11.9 million and $3.3 million, respectively. The decrease related to the Nuclear Services Group segment was primarily attributable to the $7.9 million settlement of the contract dispute noted above. These decreases were partially offset by operating income improvements in the Nuclear Power Group segment of $2.1 million. Unallocated corporate expenses also decreased by $1.4 million when compared to the corresponding period of 2017.
Six months ended June 30, 2018 vs. 2017
Consolidated revenues increased 6.9%, or $58.1 million, to $896.4 million in the six months ended June 30, 2018 compared to $838.2 million for the corresponding period in 2017, due to increases in revenues from our Nuclear Operations Group and Nuclear Power Group segments totaling $10.8 million and $56.3 million, respectively. These increases were partially offset by a decrease in revenues in our Nuclear Services Group segment of $10.0 million, which was primarily related to $7.9 million of fee income associated with the settlement of a contract dispute that was recorded in 2017.
Consolidated operating income decreased $10.3 million to $151.4 million in the six months ended June 30, 2018 compared to $161.7 million for the corresponding period of 2017. Operating income in our Nuclear Operations Group, Nuclear
Services Group and Other segments decreased $2.3 million, $11.1 million and $5.7 million, respectively. The decrease related to the Nuclear Services Group segment was primarily attributable to the $7.9 million settlement of the contract dispute noted above. Additionally, we also experienced an increase in unallocated corporate expenses of $2.0 million. These decreases were partially offset by operating income improvements in the Nuclear Power Group segment of $10.9 million.
Nuclear Operations Group
(In thousands)
| Three Months Ended June 30, 2018 | 2017 | $ Change | Six Months Ended June 30, 2018 | 2017 | $ Change | |
|---|---|---|---|---|---|---|
| Revenues | $332,140 | $312,866 | $19,274 | $648,771 | $637,947 | $10,824 |
| Operating Income | 67,046 | $69,295 | (2,249) | 134,703 | 137,044 | (2,341) |
| % of Revenues | 20.2% | 22.1% | 20.8% | 21.5% |
Three months ended June 30, 2018 vs. 2017
Revenues increased 6.2%, or $19.3 million, to $332.1 million in the three months ended June 30, 2018 compared to $312.9 million for the corresponding period of 2017. The increase was primarily attributable to increased activity in the manufacturing of nuclear components for U.S. Government programs as well as our naval nuclear fuel and downblending operations.
Operating income decreased $2.2 million to $67.0 million in the three months ended June 30, 2018 compared to $69.3 million for the corresponding period of 2017. The decrease was primarily driven by higher costs which were partially offset by the increase in revenues noted above.
Six months ended June 30, 2018 vs. 2017
Revenues increased 1.7%, or $10.8 million, to $648.8 million in the six months ended June 30, 2018 compared to $637.9 million for the corresponding period of 2017. The increase was primarily attributable to increased activity in the manufacturing of nuclear components for U.S. Government programs as well as our naval nuclear fuel and downblending operations.
Operating income decreased $2.3 million to $134.7 million in the six months ended June 30, 2018 compared to $137.0 million for the corresponding period of 2017. The decrease was primarily driven by higher costs which were partially offset by the increase in revenues noted above.
Nuclear Services Group
(In thousands)
| Three Months Ended June 30, 2018 | 2017 | $ Change | Six Months Ended June 30, 2018 | 2017 | $ Change | |
|---|---|---|---|---|---|---|
| Revenues | $32,596 | $44,785 | $(12,189) | $62,629 | $72,639 | $(10,010) |
| Operating Income | 3,511 | 15,399 | (11,888) | 4,688 | 15,801 | (11,113) |
| % of Revenues | 10.8% | 34.4% | 7.5% | 21.8% |
Three months ended June 30, 2018 vs. 2017
Revenues decreased 27.2%, or $12.2 million, to $32.6 million in the three months ended June 30, 2018 compared to $44.8 million for the corresponding period of 2017. The decrease was primarily attributable to the settlement of a contract dispute in the prior year which resulted in the recovery of $7.9 million of fee income. In addition, we performed fewer commercial nuclear maintenance outages in the U.S. when compared to the same period in the prior year. These decreases were partially offset by an increase in revenue attributable to task order work related to a new joint venture site in New Mexico of $3.7 million and an increase in design and engineering revenues in support of NASA's nuclear space programs totaling $1.7 million.
Operating income decreased $11.9 million to $3.5 million in the three months ended June 30, 2018 compared to $15.4 million for the corresponding period of 2017. The decrease was primarily attributable to the changes in revenues noted above as well as the settlement of the contract dispute of $7.9 million.
Six months ended June 30, 2018 vs. 2017
Revenues decreased 13.8%, or $10.0 million, to $62.6 million in the six months ended June 30, 2018 compared to $72.6 million for the corresponding period of 2017. The decrease was primarily attributable to the settlement of a contract dispute in the prior year which resulted in the recovery of $7.9 million of fee income. In addition, we performed fewer commercial nuclear maintenance outages in the U.S. when compared to the same period in the prior year. These decreases were partially offset by an increase in revenue attributable to task order work related to a new joint venture site in New Mexico of $5.5 million and an increase in design and engineering revenues in support of NASA's nuclear space programs totaling $3.3 million.
Operating income decreased $11.1 million to $4.7 million in the six months ended June 30, 2018 compared to $15.8 million for the corresponding period of 2017. The decrease was primarily attributable to the changes in revenues noted above as well as the settlement of the contract dispute of $7.9 million.
Nuclear Power Group
(In thousands)
| Three Months Ended June 30, 2018 | 2017 | $ Change | Six Months Ended June 30, 2018 | 2017 | $ Change | |
|---|---|---|---|---|---|---|
| Revenues | $75,697 | $54,569 | $21,128 | $188,513 | $132,243 | $56,270 |
| Operating Income | 7,810 | 5,712 | 2,098 | 29,574 | 18,668 | 10,906 |
| % of Revenues | 10.3% | 10.5% | 15.7% | 14.1% |
Three months ended June 30, 2018 vs. 2017
Revenues increased 38.7%, or $21.1 million, to $75.7 million in the three months ended June 30, 2018 compared to $54.6 million for the corresponding period of 2017. The increase was attributable to higher levels of in-plant inspection, maintenance and modification services, as well as refurbishment work totaling $16.2 million. In addition, we experienced an increase in revenues in our nuclear components business of $4.0 million.
Operating income increased $2.1 million to $7.8 million in the three months ended June 30, 2018 compared to $5.7 million for the corresponding period of 2017, primarily attributable to the increases in revenues noted above.
Six months ended June 30, 2018 vs. 2017
Revenues increased 42.6%, or $56.3 million, to $188.5 million in the six months ended June 30, 2018 compared to $132.2 million for the corresponding period of 2017. The increase was attributable to higher levels of in-plant inspection, maintenance and modification services, as well as refurbishment work totaling $27.3 million. In addition, we experienced an increase in revenues in our nuclear components business of $21.7 million primarily as a result of an increase in design and manufacturing work associated with the China steam generator project as well as higher volume related to the fabrication of nuclear fuel.
Operating income increased $10.9 million to $29.6 million in the six months ended June 30, 2018 compared to $18.7 million for the corresponding period of 2017, primarily attributable to the increases in revenue noted above. In addition, operating income improved as a result of lower selling, general and administrative expenses, which was largely related to the integration of BWXT Nuclear Energy Canada Inc. (acquired December 16, 2016) into our existing business.
Other
(In thousands)
| Three Months Ended June 30, 2018 | 2017 | $ Change | Six Months Ended June 30, 2018 | 2017 | $ Change | |
|---|---|---|---|---|---|---|
| Operating Income | (4,357) | (1,070) | (3,287) | (8,400) | (2,682) | (5,718) |
Operating income decreased $3.3 million and $5.7 million in the three and six months ended June 30, 2018, primarily due to an increase in research and development activities related to our medical and industrial radioisotope capabilities.
Unallocated Corporate
Unallocated corporate expenses decreased $1.4 million to $2.5 million for the three months ended June 30, 2018 compared to $3.9 million for the corresponding period of 2017. This decrease was primarily due to lower levels of stock-based compensation.
Unallocated corporate expenses increased $2.0 million to $9.1 million for the six months ended June 30, 2018 compared to $7.1 million for the corresponding period of 2017. This increase was primarily due to legal and consulting costs associated with due diligence activities and higher healthcare claims, which were partially offset by lower levels of stock-based compensation.
Other Income Statement Items
Other – net increased $4.6 million to a gain of $7.7 million in the three months ended June 30, 2018, as compared to a gain of $3.1 million for the corresponding period of 2017 due primarily to $6.0 million of gains related to derivative instruments not designated as hedges and a decrease in net periodic benefit cost. These items were partially offset by an increase in interest expense of $4.0 million associated with higher levels of long-term debt when compared to the prior year. Included in interest expense is $2.4 million of expense related to the recognition of prior deferred debt issuance costs associated with the Former Credit Facility.
Other – net increased $5.6 million to a gain of $12.8 million in the six months ended June 30, 2018, as compared to a gain of $7.2 million for the corresponding period of 2017 due primarily to $6.0 million of gains related to derivative instruments not designated as hedges and a decrease in net periodic benefit cost. These items were partially offset by an increase in interest expense of $4.0 million associated with higher levels of long-term debt when compared to the prior year. Included in interest expense is $2.4 million of expense related to the recognition of prior deferred debt issuance costs associated with the Former Credit Facility.
Provision for Income Taxes
(In thousands)
| Three Months Ended June 30, 2018 | 2017 | $ Change | Six Months Ended June 30, 2018 | 2017 | $ Change | |
|---|---|---|---|---|---|---|
| Income before Provision for Income Taxes | $79,227 | $88,482 | $(9,255) | $164,243 | $168,860 | $(4,617) |
| Provision for Income Taxes | $18,493 | $27,062 | $(8,569) | $37,096 | $51,654 | $(14,558) |
| Effective Tax Rate | 23.3% | 30.6% | 22.6% | 30.6% |
We primarily operate in the U.S. and Canada. On December 22, 2017, the Tax Cuts and Jobs Act (the "Act") was enacted, making significant changes to existing U.S. tax laws that impact BWXT, including, but not limited to, a reduction to the U.S. corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017, the taxation of global intangible low-taxed income (GILTI) and additional deduction limitations related to executive compensation. We recognized the income tax effects of the Act within our condensed consolidated financial statements in accordance with Financial Accounting Standards Board Topic Income Taxes. Our Canadian operations continue to be subject to tax at a local statutory rate of approximately 25%.
Our effective tax rate for the three months ended June 30, 2018 was 23.3% as compared to 30.6% for the three months ended June 30, 2017. Our effective tax rate for the six months ended June 30, 2018 was 22.6% as compared to 30.6% for the six months ended June 30, 2017. The effective tax rate for the three and six months ended June 30, 2018 were slightly higher than the U.S. corporate income tax rate of 21% primarily due to state income taxes within the U.S. and the unfavorable rate differential associated with our Canadian earnings. Our effective tax rate for the three months ended June 30, 2018 and 2017 was favorably impacted by benefits recognized for excess tax benefits related to employee share-based payments of $0.2 million and $2.6 million, respectively. Our effective tax rate for the six months ended June 30, 2018 and 2017 was favorably impacted by benefits recognized for excess tax benefits related to employee share-based payments of $2.4 million and $4.9 million, respectively.
Backlog
Backlog represents the dollar amount of revenue we expect to recognize in the future from contracts awarded and in progress. Not all of our expected revenue from a contract award is recorded in backlog for a variety of reasons, including that some projects are awarded and completed within the same fiscal quarter.
Our backlog is equal to our remaining performance obligations under contracts that meet the criteria in FASB Topic Revenue from Contracts with Customers, as discussed in Note 2 to our condensed consolidated financial statements included in this Report. It is possible that our methodology for determining backlog may not be comparable to methods used by other companies.
We are subject to the budgetary and appropriations cycle of the U.S. Government as it relates to our Nuclear Operations Group and Nuclear Services Group segments. Backlog may not be indicative of future operating results, and projects in our backlog may be cancelled, modified or otherwise altered by customers.
| June 30, 2018 (In approximate millions) | December 31, 2017 | |
|---|---|---|
| Nuclear Operations Group | $2,686 | $3,305 |
| Nuclear Services Group | 44 | 29 |
| Nuclear Power Group | 883 | 637 |
| Total Backlog | $3,613 | $3,971 |
We do not include the value of our unconsolidated joint venture contracts in backlog. These unconsolidated joint ventures are included in our Nuclear Services Group segment.
Of the June 30, 2018 backlog, we expect to recognize revenues as follows:
| 2018 (In approximate millions) | 2019 | Thereafter | Total | |
|---|---|---|---|---|
| Nuclear Operations Group | $630 | $798 | $1,258 | $2,686 |
| Nuclear Services Group | 35 | 3 | 6 | 44 |
| Nuclear Power Group | 141 | 143 | 599 | 883 |
| Total Backlog | $806 | $944 | $1,863 | $3,613 |
At June 30, 2018, Nuclear Operations Group backlog with the U.S. Government was $2,677.8 million, $252.4 million of which had not yet been funded.
At June 30, 2018, Nuclear Services Group backlog with the U.S. Government was $26.7 million, all of which was funded.
At June 30, 2018, Nuclear Power Group had no backlog with the U.S. Government.
Major new awards from the U.S. Government are typically received following congressional approval of the budget for the Government's next fiscal year, which starts October 1, and may not be awarded to us before the end of the calendar year. Due to the fact that most contracts awarded by the U.S. Government are subject to these annual funding approvals, the total values of the underlying programs are significantly larger. In April 2016, we were awarded a component and fuel contract, along with a three-year downblending contract by the U.S. Government with a combined value in excess of $3.0 billion, inclusive of unexercised options.
As of June 30, 2018, the U.S. Government had awarded us approximately $2.8 billion of the April 2016 award. The value of unexercised options excluded from backlog as of June 30, 2018 was approximately $0.2 billion, the majority of which is expected to be exercised in 2019, subject to annual congressional appropriations.
Liquidity and Capital Resources
On May 24, 2018, we and certain of our subsidiaries entered into a credit agreement (the "New Credit Facility") with Wells Fargo Bank, N.A., as administrative agent, and the other lenders party thereto. We also issued notes pursuant to an indenture among the Company, certain of our subsidiaries, as guarantors, and U.S. Bank National Association, as trustee. In connection with the closing of the New Credit Facility and the issuance of the notes, we concurrently repaid all outstanding debt obligations and terminated our credit agreement dated as of May 11, 2015, as amended, among the Company, certain of our subsidiaries, Bank of America, N.A., as administrative agent, and the other lenders party thereto (the "Former Credit Facility"). The Former Credit Facility consisted of (1) a $400.0 million revolving credit facility, (2) a $300.0 million term loan facility, (3) a $137.5 million (U.S. dollar equivalent) Canadian dollar term loan facility, and (4) a $112.5 million term loan facility.
Credit Facility
The New Credit Facility includes a $500.0 million senior secured revolving credit facility (the "New Revolving Credit Facility"), a $50.0 million U.S. dollar senior secured term loan A made available to the Company (the "New USD Term Loan") and a $250.0 million (U.S. dollar equivalent) Canadian dollar senior secured term loan A made available to BWXT Canada Ltd. (the "New CAD Term Loan"). All obligations under the New Credit Facility are scheduled to mature on May 24, 2023. The proceeds of loans under the New Credit Facility are available for working capital needs and other general corporate purposes.
The New Credit Facility allows for additional parties to become lenders and, subject to certain conditions, for the increase of the commitments under the New Revolving Credit Facility, the New USD Term Loan or the New CAD Term Loan, subject to an aggregate maximum for all additional commitments of (1) the greater of (a) $250 million and (b) 65% of EBITDA, as defined in the New Credit Facility, for the last four full fiscal quarters, plus (2) all voluntary prepayments of term loans, plus (3) additional amounts provided the Company is in compliance with a pro forma first lien leverage ratio test of less than or equal to 2.50 to 1.00.
The Company's obligations under the New Credit Facility are guaranteed, subject to certain exceptions, by substantially all of the Company's present and future wholly owned domestic restricted subsidiaries (other than its captive insurance subsidiary and the domestic holding company of its Canadian subsidiaries). The obligations of BWXT Canada Ltd. under the New Credit Facility are guaranteed, subject to certain exceptions, by (1) substantially all of the present and future wholly owned Canadian restricted subsidiaries of BWXT Canada Ltd., (2) substantially all of the Company's present and future wholly owned domestic restricted subsidiaries (other than its captive insurance subsidiary and the domestic holding company of its Canadian subsidiaries), (3) BWXT Canada Holdings Corp. and (4) BWXT ITG Canada Inc.
The New Credit Facility is secured by first-priority liens on certain assets owned by the Company (other than its subsidiaries comprising its Nuclear Operations Group segment and a portion of its Nuclear Services Group segment); provided that (1) the Company's domestic obligations are only secured by assets and property of the domestic loan parties and (2) the obligations of BWXT Canada Ltd. and the Canadian guarantors are secured by assets and property of the Canadian guarantors and the domestic loan parties.
The New Credit Facility requires interest payments on revolving loans on a periodic basis until maturity. We will be required to make quarterly amortization payments on the New USD Term Loan and the New CAD Term Loan in an amount equal to 1.25% of the initial aggregate principal amount of each term loan beginning in the third quarter of 2018. We may prepay all loans under the New Credit Facility at any time without premium or penalty (other than customary Eurocurrency breakage costs), subject to notice requirements.
The New Credit Facility includes financial covenants that are tested on a quarterly basis, based on the rolling four-quarter period that ends on the last day of each fiscal quarter. The maximum permitted leverage ratio is 4.00 to 1.00, which may be increased to 4.50 to 1.00 for up to four consecutive fiscal quarters after a material acquisition. The minimum consolidated interest coverage ratio is 3.00 to 1.00. In addition, the New Credit Facility contains various restrictive covenants, including with respect to debt, liens, investments, mergers, acquisitions, dividends, equity repurchases and asset sales. As of June 30, 2018, we were in compliance with all covenants set forth in the New Credit Facility.
Outstanding loans under the New Credit Facility will bear interest at our option at either (1) the Eurocurrency rate plus a margin ranging from 1.25% to 2.00% per year or (2) the base rate or Canadian index rate, as applicable (described in the New Credit Facility as the highest of (a) with respect to the base rate only, the federal funds rate plus 0.50%, (b) the one-month Eurocurrency rate plus 1.0% and (c) the administrative agent's prime rate or the Canadian prime rate, as applicable), plus, in each case, a margin ranging from 0.25% to 1.00% per year. We are charged a commitment fee on the unused portion of the New Revolving Credit Facility, and that fee ranges from 0.150% to 0.275% per year. Additionally, we are charged a letter of credit fee of between 1.25% and 2.00% per year with respect to the amount of each financial letter of credit issued under the New Credit Facility, and a letter of credit fee of between 0.75% and 1.20% per year is charged with respect to the amount of each performance letter of credit issued under the New Credit Facility. The applicable margin for loans, the commitment fee and the letter of credit fees set forth above will vary quarterly based on our leverage ratio. Based on the leverage ratio applicable at June 30, 2018, the margin for Eurocurrency rate and base rate or Canadian index rate loans was 1.375% and 0.375%, respectively, the letter of credit fee for financial letters of credit and performance letters of credit was 1.375% and 0.825%, respectively, and the commitment fee for the unused portion of the New Revolving Credit Facility was 0.175%.
As of June 30, 2018, borrowings outstanding totaled $291.1 million and $0.0 million under our term loans and revolving line of credit, respectively, and letters of credit issued under the New Credit Facility totaled $71.5 million. As a result, we had $428.5 million available for borrowings or to meet letter of credit requirements as of June 30, 2018. As of June 30, 2018, the weighted-average interest rate on outstanding borrowings under our New Credit Facility was 3.09%.
The New Credit Facility generally includes customary events of default for a secured credit facility, some of which allow for an opportunity to cure. Under the New Credit Facility, (1) if an event of default relating to bankruptcy or other insolvency events occurs, all related obligations will immediately become due and payable; (2) if any other event of default exists, the lenders will be permitted to accelerate the maturity of the related obligations outstanding and (3) if any event of default exists, the lenders will be permitted to terminate their commitments thereunder and exercise other rights and remedies, including the commencement of foreclosure or other actions against the collateral.
If any default occurs under the New Credit Facility, or if we are unable to make any of the representations and warranties in the New Credit Facility, we will be unable to borrow funds or have letters of credit issued under the New Credit Facility.
Senior Notes
The Company issued $400.0 million aggregate principal amount of its 5.375% senior notes due 2026 (the "Senior Notes") pursuant to an indenture dated May 24, 2018 (the "Indenture"), among the Company, the guarantors and U.S. Bank National Association, as trustee. The Senior Notes are guaranteed by each of the Company's present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the New Credit Facility.
Interest on the Senior Notes is payable semi-annually in cash in arrears on January 15 and July 15 of each year, commencing on July 15, 2018, at a rate of 5.375% per annum. The Senior Notes will mature on July 15, 2026.
The Company may redeem the Senior Notes, in whole or in part, at any time on or after July 15, 2021 at established redemption prices. At any time prior to July 15, 2021, the Company may also redeem up to 40% of the Senior Notes with net cash proceeds of certain equity offerings at a redemption price equal to 105.375% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, at any time prior to July 15, 2021, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date plus an applicable "make-whole" premium.
The Indenture contains customary events of default, including, among other things, payment default, failure to comply with covenants or agreements contained in the Indenture or the Senior Notes and certain provisions related to bankruptcy events. The Indenture also contains customary negative covenants. As of June 30, 2018, we were in compliance with all covenants and agreements set forth in the Indenture and the Senior Notes.
Other Arrangements
We have posted surety bonds to support regulatory and contractual obligations for certain decommissioning responsibilities, projects and legal matters. We utilize bonding facilities to support such obligations, but the issuance of bonds under those facilities is typically at the surety's discretion. Although there can be no assurance that we will maintain our surety bonding capacity, we believe our current capacity is adequate to support our existing requirements for the next twelve months. In addition, these bonds generally indemnify the beneficiaries should we fail to perform our obligations under the applicable agreements. We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds those underwriters issue. As of June 30, 2018, bonds issued and outstanding under these arrangements totaled approximately $60.9 million.
Long-term Benefit Obligations
Our unfunded pension and postretirement benefit obligations totaled $265.7 million at June 30, 2018. These long-term liabilities are expected to require use of our resources to satisfy future funding obligations. Based largely on statutory funding requirements, we expect to make contributions of approximately $14.2 million for the remainder of 2018 related to our pension and postretirement plans. We may also make additional contributions based on a variety of factors including, but not limited to, tax planning, evaluation of funded status and risk mitigation strategies.
Other
Our domestic and foreign cash and cash equivalents, restricted cash and cash equivalents and investments as of June 30, 2018 and December 31, 2017 were as follows:
(In thousands)
| June 30, 2018 | December 31, 2017 | |
|---|---|---|
| Domestic | $126,320 | $211,935 |
| Foreign | 210,576 | 13,443 |
| Total | $336,896 | $225,378 |
Our working capital increased by $236.3 million to $581.3 million at June 30, 2018 from $345.0 million at December 31, 2017, primarily attributable to an increase in cash and cash equivalents as a result of issuing the Senior Notes and closing of the New Credit Facility as well as changes in net contracts in progress and advance billings due to the timing of project cash flows.
Our net cash provided by operations decreased by $46.8 million to $17.3 million in the six months ended June 30, 2018, compared to $64.1 million in the six months ended June 30, 2017. The decrease in cash provided by operations was largely attributable to the changes in net contracts in progress and advance billings noted above as well as the payment of cash taxes of $49.8 million in the six months ended June 30, 2018 compared to $34.0 million in the six months ended June 30, 2017.
Our net cash used in investing activities increased by $20.9 million to $41.4 million in the six months ended June 30, 2018 compared to $20.5 million in the six months ended June 30, 2017. The increase was primarily attributable to a net decrease in purchases and sales and maturities of securities of $6.8 million and increases in net investments in equity method investees of $10.0 million and purchases of property, plant and equipment of $5.2 million.
Our net cash provided by financing activities increased by $174.3 million to $147.7 million in the six months ended June 30, 2018, compared to cash used in financing activities of $26.6 million in the six months ended June 30, 2017. The increase was primarily attributable to an increase in net borrowings of $203.8 as a result of issuing the Senior Notes and closing of the New Credit Facility. The increase in net borrowings was partially offset by the payment of debt issuance costs of $8.2 million as well as an increase in dividends paid to common shareholders of $11.9 million.
At June 30, 2018, we had restricted cash and cash equivalents totaling $8.5 million, $2.6 million of which was held for future decommissioning of facilities (which is included in other assets on our condensed consolidated balance sheets) and $5.9 million of which was held to meet reinsurance reserve requirements of our captive insurer.
At June 30, 2018, we had short-term and long-term investments with a fair value of $10.8 million. Our investment portfolio consists primarily of U.S. Government and agency securities, corporate bonds and equities, mutual funds and asset-backed securities. Our investments are carried at fair value and are either classified as trading, with unrealized gains and losses reported in earnings, or as available-for-sale, with unrealized gains and losses, net of tax, being reported as a component of other comprehensive income.
Based on our liquidity position, we believe we have sufficient cash and letter of credit and borrowing capacity to fund our operating requirements for at least the next 12 months.
Market risk
As filed, 1,498 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our exposures to market risks have not changed materially from those disclosed in Item 7A included in Part II of our 2017 10-K, except as set forth below.
Our borrowings include both fixed and variable interest rate debt. We have exposure to changes in interest rates on the New Credit Facility (see Item 2 – "Management's Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources"). At June 30, 2018, we had (i) $291.1 million in outstanding borrowings and $428.5 million available under the New Credit Facility, and (ii) an aggregate principal amount of $400.0 million of Senior Notes due 2026.
Interest Rate Sensitivity
The following tables provide information about our financial instruments that are sensitive to changes in interest rates. The tables present principal cash flows and related weighted-average interest rates by expected maturity dates.
| At June 30, 2018: | Principal Amount by Expected Maturity (In thousands) Years Ending December 31, 2018 | 2019 | 2020 | 2021 | 2022 | Thereafter | Total | Fair Value at June 30, 2018 |
|---|---|---|---|---|---|---|---|---|
| Fixed Interest Rate Debt | — | — | — | — | — | $400,000 | $400,000 | $405,256 |
| Average Interest Rate | — | — | — | — | — | 5.38% | ||
| Variable Interest Rate Debt | $7,278 | $14,556 | $14,556 | $14,556 | $14,556 | $225,626 | $291,128 | $289,465 |
| Average Interest Rate | 3.35% | 3.72% | 3.90% | 3.95% | 3.96% | 3.96% |
Controls and procedures
As filed, 1,994 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
As of the end of the period covered by this quarterly report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) adopted by the SEC under the Securities Exchange Act of 1934, as amended (the "Exchange Act")). This evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer. Our disclosure controls and procedures were developed through a process in which our management applied its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding the control objectives. You should note that the design of any system of disclosure controls and procedures is based in part upon various assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. Based on the evaluation referred to above, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures are effective as of June 30, 2018 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding disclosure. There has been no change in our internal control over financial reporting during the quarter ended June 30, 2018 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II
OTHER INFORMATION
Risk factors
As filed, 322 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the other information in this report, the other factors presented in Item 1A Risk Factors in our 2017 10-K are some of the factors that could materially affect our business, financial condition or future results. There have been no material changes to our risk factors from those disclosed in our 2017 10-K.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-04-01 to 2018-06-30 | $440.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2018-01-01 to 2018-06-30 | $899.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2018-04-01 to 2018-06-30 | $318.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2018-01-01 to 2018-06-30 | $645.6m | us-gaap:CostOfRevenue |
| Research and development | 3 months2018-04-01 to 2018-06-30 | $4.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-01-01 to 2018-06-30 | $7.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2018-04-01 to 2018-06-30 | $51.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2018-01-01 to 2018-06-30 | $105.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | $71.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | $151.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-04-01 to 2018-06-30 | $7.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2018-01-01 to 2018-06-30 | $11.4m | us-gaap:InterestExpense |
| Income tax | 3 months2018-04-01 to 2018-06-30 | $18.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-01-01 to 2018-06-30 | $37.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-04-01 to 2018-06-30 | $60.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | $127.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | $0.60 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | $1.26 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-04-01 to 2018-06-30 | $0.61 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-01-01 to 2018-06-30 | $1.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-04-01 to 2018-06-30 | 100,571,737 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-01-01 to 2018-06-30 | 100,542,014 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | $17.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-01-01 to 2018-06-30 | $34.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2018-01-01 to 2018-06-30 | $32.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2018-06-30 | $317.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $890.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $1.74bn | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $309.4m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2018-06-30 | $666.2m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2018-06-30 | $388.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001486957-18-000037. Last ingested by Listed: Nov 14, 2026, 19:14 ET. Listed shows no prices and gives no investment advice.